BlossomHill 制药 BLSM
$13.50 +$1.15 (+9.31%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $13.50 0.00%
开盘$12.29
昨收$12.35
当日区间$12.14 – $14.09
成交量174.3K
市值$429.10M
市盈率（TTM）–
股息率–
BLSM 相关新闻
匹配 BlossomHill Therapeutics 或代码 BLSM 的头条新闻，按最新排序。
- H.C. Wainwright Maintains BlossomHill Therapeutics(BLSM.US) With Buy Rating, Maintains Target Price $35
- Analysts Offer Insights on NA Companies: Expedia (EXPE) and BlossomHill Therapeutics, Inc. (BLSM)
- Analysts Conflicted on These NA Names: Guardian Metal Resources PLC Sponsored ADR (GMTL), BlossomHill Therapeutics, Inc. (BLSM) and International Paper Co (IP)
- J.P. Morgan Maintains BlossomHill Therapeutics(BLSM.US) With Buy Rating, Announces Target Price $30
- Leerink Partners Initiates BlossomHill Therapeutics(BLSM.US) With Buy Rating, Announces Target Price $40
- Analysts Are Bullish on These NA Stocks: BlossomHill Therapeutics, Inc. (BLSM), Micron (MU) 正面
- A Quick Look at Today's Ratings for BlossomHill Therapeutics(BLSM.US), With a Forecast Between $28 to $35
- J.P. Morgan Maintains BlossomHill Therapeutics(BLSM.US) With Buy Rating
- Analysts Offer Insights on NA Companies: BlossomHill Therapeutics, Inc. (BLSM), Amrize Ltd (AMRZ) and ServiceTitan, Inc. Class A (TTAN)
- LifeSci Capital Maintains BlossomHill Therapeutics(BLSM.US) With Buy Rating, Maintains Target Price $32
- Guggenheim Maintains BlossomHill Therapeutics(BLSM.US) With Buy Rating, Maintains Target Price $40
- Analysts Offer Insights on NA Companies: Turn Therapeutics Inc (TTRX) and BlossomHill Therapeutics, Inc. (BLSM)
暂无评论——快来第一个聊聊 BLSM。
登录后参与讨论。